PTPN13 and neoplasm: Mutation of this residue (V2860A in murine APC or V2843A in human APC) significantly impaired the interaction between APC and PTPN13, leading to reduced activation of IFNγ-STAT1 signaling, lower immune cell infiltration, and greater tumor growth, without affecting the interaction between APC and β-catenin.